Prosight Management, LP Portfolio
Auto-discovered 13F filer (Top-2000 by latest reported value).
SEC 13F CIK: 0001617201
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Q1 2024 · 44 positions · Total reported value $359.45M · Top-10 concentration 62.0% · Updated 2026-10-18
Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR
Turnover: 75.6% · 9 new · 12 cut · 13 exited
Active Share (vs S&P 500): 99.8% · vs QQQ: 99.9% — share of the book that differs from index weights (higher = more active) · ranking
Est. Qtr Return (Q2 2026 → Q3 2026): -1.1% · vs SPY -3.2% · Prev Value $580.35M — last quarter positions weighted by this quarter price moves · ranking
Est. QTD Return (Q3 2026 → newest close): -6.1% · vs SPY -8.3% · Latest Value $515.48M — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking
In its Q1 2024 13F filing, Prosight Management, LP disclosed 44 equity positions with a combined reported value of $359.45M. The filing implies a focused portfolio: its ten largest positions account for 62.0% of reported value. HoldingsHub classifies the profile as Small / Focused / Health Tilt / High Turnover.
The largest disclosed positions as of Q1 2024 were STTK ($33.30M), ADCT ($31.66M), LKFT ($29.99M). By sector, the heaviest allocations are Health Care 87.1%, Consumer Discretionary 3.3%. Versus the prior quarter, allocation shifted toward Health Care (+7.8pp), Consumer Discretionary (+2.6pp) and away from Other (-10.7pp).
Versus the prior quarter, Prosight Management, LP opened 9 new positions, trimmed 12 and fully exited 13, a turnover rate of 75.6% of positions. The portfolio's overlap with the prior quarter was 47% of names.
The largest new positions opened in Q1 2024 were ROIV ($19.60M), BBIO ($18.23M), CYTK ($17.18M).
Of the 13 positions fully exited versus the prior quarter, the largest were QDEL ($8.76M), GRPH ($3.54M), MDRX ($1.89M).
Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.
New Positions (Q1 2024)
- ROIV ROIVANT SCIENCES LTD · $19.60M
- BBIO BRIDGEBIO PHARMA INC · $18.23M
- CYTK CYTOKINETICS INC · $17.18M
- GH GUARDANT HEALTH INC · $9.70M
- KELYA KELLY SVCS INC · $8.73M
- IMVT IMMUNOVANT INC · $6.30M
- PFE PFIZER INC · $5.97M
- MRVI MARAVAI LIFESCIENCES HLDGS I · $5.20M
Fully Exited (vs previous quarter)
- QDEL QUIDELORTHO CORP · prev qtr: $8.76M
- GRPH GRAPHITE BIO INC · prev qtr: $3.54M
- MDRX VERADIGM INC · prev qtr: $1.89M
- ORIC ORIC PHARMACEUTICALS INC · prev qtr: $1.84M
- SYRE SPYRE THERAPEUTICS INC · prev qtr: $1.18M
- SWAV SHOCKWAVE MEDICAL INC · prev qtr: $952.80K
- DSGN DESIGN THERAPEUTICS INC · prev qtr: $742.00K
Insider Transactions (Form 4)
Latest Prosight Management, LP buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.
No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.
Fund Profile
Prosight Management, LP is an SEC-registered 13F filer based in Dallas, TX, United States. As of Q2 2026 it reported 36 US equity positions with a combined value of $580.35M. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).
Firm Snapshot
- Headquarters: DALLAS, TX, United States
- SEC registration: 801-108047 (status: Approved), registered 2016-07-01
- Regulatory AUM (Form ADV): $1.04B as of 2026-03-30
- Client mix (by RAUM): pension and profit-sharing plans 100%
- Manages 2 private funds, of which 2 hedge funds
- Website: prosightcapital.com
Portfolio Structure
- 36 positions · $580.35M reported value (Q2 2026)
- Top 10 holdings = 70.7% of reported value
- Largest position: LKFT (LAKEFRONT BIOTHERAPEUTICS NV) at 10.6%
- Average position size: $16.12M
Sector Tilt
- Health Care 83.6%
- Information Technology 3.2%
- (classified holdings cover 87% of value)
Quarterly Activity
- Q2 2026: 5 new, 16 added, 15 reduced, 15 exited
Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.
| # | Company | Shares | Value | Weight | Allocation | Change |
|---|---|---|---|---|---|---|
| 1 |
|
3.73M | $33.30M | 9.26% | Add | |
| 2 |
|
7.05M | $31.66M | 8.81% | Add | |
| 3 |
|
931.51K | $29.99M | 8.35% | Add | |
| 4 |
|
4.02M | $24.39M | 6.78% | Reduce | |
| 5 |
|
960.00K | $20.48M | 5.70% | Add | |
| 6 |
|
1.86M | $19.60M | 5.45% | New | |
| 7 |
|
589.53K | $18.23M | 5.07% | New | |
| 8 |
|
245.00K | $17.18M | 4.78% | New | |
| 9 |
|
180.00K | $15.69M | 4.36% | Reduce | |
| 10 |
|
418.26K | $12.20M | 3.39% | Add | |
| 11 |
|
465.00K | $11.68M | 3.25% | Add | |
| 12 |
|
470.00K | $9.70M | 2.70% | New | |
| 13 |
|
348.69K | $8.73M | 2.43% | New | |
| 14 |
|
1.79M | $8.11M | 2.26% | Add | |
| 15 |
|
3.66M | $7.54M | 2.10% | Add | |
| 16 |
|
1.40M | $7.11M | 1.98% | Reduce | |
| 17 |
|
195.00K | $6.30M | 1.75% | New | |
| 18 |
|
215.00K | $5.97M | 1.66% | New | |
| 19 |
|
215.00K | $5.82M | 1.62% | Add | |
| 20 |
|
30.00K | $5.47M | 1.52% | Add | |
| 21 |
|
599.46K | $5.20M | 1.45% | New | |
| 22 |
|
410.95K | $4.32M | 1.20% | New | |
| 23 |
|
170.47K | $4.22M | 1.18% | Reduce | |
| 24 |
|
30.50K | $4.21M | 1.17% | Reduce | |
| 25 |
|
100.62K | $3.95M | 1.10% | New | |
| 26 |
|
450.00K | $3.73M | 1.04% | New | |
| 27 |
|
555.50K | $3.73M | 1.04% | New | |
| 28 |
|
100.00K | $3.35M | 0.93% | Reduce | |
| 29 |
|
39.05K | $3.20M | 0.89% | New | |
| 30 |
|
23.00K | $3.19M | 0.89% | Hold | |
| 31 |
|
24.00K | $3.04M | 0.85% | Add | |
| 32 |
|
983.20K | $3.00M | 0.83% | New | |
| 33 |
|
94.36K | $2.76M | 0.77% | Reduce | |
| 34 |
|
18.91K | $2.50M | 0.69% | New | |
| 35 |
|
400.00K | $1.96M | 0.54% | Reduce | |
| 36 |
|
65.00K | $1.45M | 0.40% | New | |
| 37 |
|
30.00K | $1.13M | 0.31% | New | |
| 38 |
|
75.00K | $1.12M | 0.31% | Add | |
| 39 |
|
250.00K | $910.00K | 0.25% | Reduce | |
| 40 |
|
45.00K | $881.55K | 0.24% | Reduce | |
| 41 |
|
963.60K | $868.78K | 0.24% | Reduce | |
| 42 |
|
25.00K | $731.00K | 0.20% | New | |
| 43 |
|
566.52K | $725.14K | 0.20% | New | |
| 44 |
|
25.00K | $142.00K | 0.04% | New | |
FAQ
What did Prosight Management, LP buy in 2024-Q1?
In its 2024-Q1 13F filing, Prosight Management, LP reported 44 equity positions worth $359.45M in aggregate; its largest disclosed positions were STTK ($33.30M), ADCT ($31.66M), LKFT ($29.99M).
How large is Prosight Management, LP's portfolio?
Prosight Management, LP reported $359.45M of long equity holdings across 44 positions as of 2024-Q1. Top-10 holdings account for 62.0% of reported value.
What is Prosight Management, LP's investment style?
HoldingsHub classifies the portfolio as Small / Focused / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.
Where does this data come from?
All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.